跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule
Approved
STANDARD
TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9955c227ea31e056
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
9955c227ea31e056
Product Name
TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule
Artg Id
157812
Artg Name
TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2010-08-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-07201-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-07200-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9955c227ea31e056
Type
Standard
Back to TGA Approvals